Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”

Detalles Bibliográficos
Autores principales: Karlsson, Jan Olof G., Jynge, Per, Lundström, Ingemar, Ignarro, Louis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591909/
https://www.ncbi.nlm.nih.gov/pubmed/31234946
http://dx.doi.org/10.1186/s13063-019-3476-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591909/
https://www.ncbi.nlm.nih.gov/pubmed/31234946
http://dx.doi.org/10.1186/s13063-019-3476-3

Ejemplares similares